Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HEALTH & BEAUTY OF SCANDINAVIA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   2.1% 1.8% 4.2% 3.0% 5.6% 5.3% 9.6% 9.6%   Credit score (0-100)   69 73 48 56 40 41 26 26   Credit rating   A A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   1.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   19,031 8,539 3,338 4,248 3,333 3,529 0.0 0.0   EBITDA   14,317 3,752 -1,329 -139 -992 -887 0.0 0.0   EBIT   13,965 3,426 -1,689 -498 -1,325 -1,134 0.0 0.0   Pre-tax profit (PTP)   13,816.2 2,577.7 -1,873.4 -447.9 -1,611.0 -1,185.2 0.0 0.0   Net earnings   10,779.4 2,006.0 -1,463.3 -351.1 -1,257.3 -927.4 0.0 0.0   Pre-tax profit without non-rec. items   13,816 2,578 -1,873 -448 -1,611 -1,185 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   2,247 2,050 1,749 1,391 1,058 811 0.0 0.0   Shareholders equity total   11,858 3,864 2,400 4,049 2,792 1,865 1,740 1,740   Interest-bearing liabilities   10,839 9,725 2,285 307 307 167 0.0 0.0   Balance sheet total (assets)   37,253 14,983 5,997 5,463 4,192 2,988 1,740 1,740   Net Debt   10,584 9,327 1,036 -813 -132 -190 -1,740 -1,740     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   19,031 8,539 3,338 4,248 3,333 3,529 0.0 0.0   Gross profit growth   -15.3% -55.1% -60.9% 27.3% -21.5% 5.9% -100.0% 0.0%   Employees   8 8 8 8 8 8 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   37,253 14,983 5,997 5,463 4,192 2,988 1,740 1,740   Balance sheet change%   19.1% -59.8% -60.0% -8.9% -23.3% -28.7% -41.8% 0.0%   Added value   14,316.6 3,752.4 -1,329.1 -139.4 -966.6 -886.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -548 -523 -660 -717 -666 -494 -811 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   73.4% 40.1% -50.6% -11.7% -39.8% -32.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   40.7% 13.1% -14.9% -5.7% -26.7% -31.4% 0.0% 0.0%   ROI %   66.3% 18.9% -17.1% -7.2% -34.6% -43.9% 0.0% 0.0%   ROE %   80.0% 25.5% -46.7% -10.9% -36.8% -39.8% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   31.8% 25.8% 40.0% 74.1% 66.6% 62.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   73.9% 248.6% -77.9% 583.5% 13.3% 21.4% 0.0% 0.0%   Gearing %   91.4% 251.7% 95.2% 7.6% 11.0% 8.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.0% 8.3% 5.2% 9.3% 104.8% 24.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 1.1 1.1 2.7 2.1 1.7 0.0 0.0   Current Ratio   1.4 1.1 1.1 2.7 2.1 1.7 0.0 0.0   Cash and cash equivalent   254.9 397.6 1,248.8 1,120.3 439.7 356.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   9,370.4 1,573.5 410.7 2,433.9 1,509.7 829.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,790 469 -166 -17 -121 -111 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,790 469 -166 -17 -124 -111 0 0   EBIT / employee   1,746 428 -211 -62 -166 -142 0 0   Net earnings / employee   1,347 251 -183 -44 -157 -116 0 0